Search Results - "EMERSON, Erling O"

PF-03814735, an orally bioavailable small molecule aurora kinase inhibitor for cancer therapy by Jani, Jitesh P, Arcari, Joel, Bernardo, Vincent, Bhattacharya, Samit K, Briere, David, Cohen, Bruce D, Coleman, Kevin, Christensen, James G, Emerson, Erling O, Jakowski, Amy, Hook, Kenneth, Los, Gerrit, Moyer, James D, Pruimboom-Brees, Ingrid, Pustilnik, Leslie, Rossi, Ann Marie, Steyn, Stefan J, Su, Chunyan, Tsaparikos, Konstantinos, Wishka, Donn, Yoon, Kwansik, Jakubczak, John L

“…The Aurora family of highly related serine/threonine kinases plays a key role in the regulation of mitosis. Aurora1 and Aurora2 play important but distinct…”
Get full text

Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor by JANI, Jitesh P, FINN, Richard S, MORRIS, Joel, MOYER, James D, PUSTILNIK, Leslie R, RAFIDI, Kristina, RALSTON, Sherry, ROSSI, Ann Marie K, STEYN, Stefanus J, WAGNER, Larry, WINTER, Steven M, BHATTACHARYA, Samit K, CAMPBELL, Mary, COLEMAN, Kevin G, CONNELL, Richard D, CURRIER, Nicolas, EMERSON, Erling O, FLOYD, Eugenia, HARRIMAN, Shawn, KATH, John C

“…Amplification and overexpression of erbB2 (Her-2/neu) proto-oncogene has been linked to human malignancies including tumors of the breast, ovary, and stomach…”
Get full text

Biochemical characterization of a mitomycin C‐resistant human bladder cancer cell line by Singh, Shivendra V., Scalamogna, Domenic, Xia, Hong, O'Toole, Stacy, Roy, Deodutta, Emerson, Erling O., Gupta, Vicram, Zaren, Howard A.

“…This study describes characteristics of a mitomycin C (MMC)‐resistant human bladder cancer cell line, J82/MMC‐2, which was established by repeated in vitro…”
Get full text

Mechanism of cross-resistance to cisplatin in a mitomycin C-resistant human bladder cancer cell line by Singh, S V, Xu, B H, Jani, J P, Emerson, E O, Backes, M G, Rihn, C, Scalamogna, D, Stemmler, N, Specht, S, Blanock, K

“…This study was undertaken to elucidate the mechanism(s) of cross-resistance to cisplatin (CDDP) in a mitomycin C (MMC)-resistant human bladder cancer cell…”
Get more information

Characterization of a human bladder cancer cell line selected for resistance to BMY 25067, a novel analogue of mitomycin C by Singh, Shivendra V., Xu, Bing H., Gupta, Vicram, Emerson, Erling O., Zaren, Howard A., Jani, Jitesh P.

“…This study describes characteristics of a human bladder cancer cell line, SCaBER/R, selected for resistance to a mitomycin C (MMC) analogue BMY 25067. The…”
Get full text